Exelixis
EXEL
#1832
Rank
A$15.58 B
Marketcap
A$58.11
Share price
-0.84%
Change (1 day)
-1.15%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company